Ischemia-Modified Albumin Levels and Thiol-Disulphide Homeostasis in Diabetic Macular Edema in Patients with Diabetes Mellitus Type 2

References

• Sabanayagam C, Banu R, Chee ML, Lee R, Wang YX, Tan G, Jonas JB, Lamoureux EL, Cheng CY, Klein BEK, et al. Incidence and progression of diabetic retinopathy: a systematic review. Lancet Diabetes Endocrinol. 2019;7(2):140–49. doi:10.1016/S2213-8587(18)30128-1.
   PubMed Web of Science ®Google Scholar
• Flaxman SR, Bourne RRA, Resnikoff S, Ackland P, Braithwaite T, Cicinelli MV, Das A, Jonas JB, Keeffe J, Kempen JH, et al. Vision loss expert group of the global burden of disease study. Global causes of blindness and distance vision impairment 1990–2020: a systematic review and meta-analysis. Lancet Glob Health. 2017;5(12):e1221–e1234. doi:10.1016/S2214-109X(17)30393-5.
   PubMed Web of Science ®Google Scholar
• Lechner J, O’Leary OE, Stitt AW. The pathology associated with diabetic retinopathy. Vision Res. 2017;139:7–14. doi:10.1016/j.visres.2017.04.003.
   PubMed Web of Science ®Google Scholar
• Gaze DC. Ischemia modified albumin: a novel biomarker for the detection of cardiac ischemia. Drug Metab Pharmacokinet. 2009;24:333–41. doi:10.2133/dmpk.24.333.
   PubMed Web of Science ®Google Scholar
• Sbarouni E, Georgiadou P, Voudris V. Ischemia modified albumin changes – review and clinical implications. Clin Chem Lab Med. 2011 January 1;49. Epub ahead of print. doi:10.1515/CCLM.2011.037.
   PubMed Web of Science ®Google Scholar
• Żurawska-Płaksej E, Grzebyk E, Marciniak D, Szymańska-Chabowska A, Piwowar A. Oxidatively modified forms of albumin in patients with risk factors of metabolic syndrome. J Endocrinol Invest. 2014;37:819–27. doi:10.1007/s40618-014-0111-8.
   PubMed Web of Science ®Google Scholar
• Can Ü, Yosunkaya Ş, New A. Marker for ischemia: ischemia-modified albumin. Kosuyolu Hear J. 2017;20:148–52. doi:10.5578/khj.10257.
   Google Scholar
• Cremers CM, Jakob U. Oxidant sensing by reversible disulfide bond formation. J Biol Chem. 2013;288:26489–96. doi:10.1074/jbc.R113.462929.
   PubMed Web of Science ®Google Scholar
• Ates I, Kaplan M, Yuksel M, Mese D, Alisik M, Erel Ö, Yilmaz N, Guler S. Determination of thiol/disulphide homeostasis in type 1 diabetes mellitus and the factors associated with thiol oxidation. Endocrine. 2016;51:47–51. doi:10.1007/s12020-015-0784-6.
   PubMed Web of Science ®Google Scholar
• Erel O, Neselioglu S. A novel and automated assay for thiol/disulphide homeostasis. Clin Biochem. 2014;47:326–32. doi:10.1016/j.clinbiochem.2014.09.026.
   PubMed Web of Science ®Google Scholar
• Bar–Or D, Lau E, Winkler JV. A novel assay for cobalt-albumin binding and its potential as a marker for myocardial ischemia—a preliminary report. J Emerg Med. 2000;19:311–15. doi:10.1016/S0736-4679(00)00255-9.
   PubMed Web of Science ®Google Scholar
• Tangvarasittichai S. Oxidative stress, insulin resistance, dyslipidemia and type 2 diabetes mellitus. World J Diabetes. 2015;6:456. doi:10.4239/wjd.v6.i3.456.
   PubMed Web of Science ®Google Scholar
• Feldman EL. Oxidative stress and diabetic neuropathy: a new understanding of an old problem. J Clin Invest. 2003;111:431–33. doi:10.1172/JCI17862.
   PubMed Web of Science ®Google Scholar
• Dzięgielewska-Gęsiak S, Wysocka E, Michalak S, Nowakowska-Zajdel E, Kokot T, Muc-Wierzgoń M. Role of lipid peroxidation products, plasma total antioxidant status, and Cu-, Zn-superoxide dismutase activity as biomarkers of oxidative stress in elderly prediabetics. Oxid Med Cell Longev. 2014;2014:1–8. doi:10.1155/2014/987303.
   Web of Science ®Google Scholar
• Kundu D, Mandal T, Nandi M, Osta M, Bandyopadhyay U, Ray D. Oxidative stress in diabetic patients with retinopathy. Ann Afr Med. 2014;13:41. doi:10.4103/1596-3519.126951.
   PubMedGoogle Scholar
• Turell L, Radi R, Alvarez B. The thiol pool in human plasma: the central contribution of albumin to redox processes. Free Radic Biol Med. 2013;65:244–53. doi:10.1016/j.freeradbiomed.2013.05.050.
   PubMed Web of Science ®Google Scholar
• Circu ML, Aw TY. Reactive oxygen species, cellular redox systems, and apoptosis. Free Radic Biol Med. 2010;48:749–62. doi:10.1016/j.freeradbiomed.2009.12.022.
   PubMed Web of Science ®Google Scholar
• Turkoglu EB, Dikci S, Çelik E, Erel Ö, Neselioglu S, Alışık M, Koca C. Thiol/ disulfide homeostasis in patients with central serous chorioretinopathy. Curr Eye Res. 2016;41:1489–91. doi:10.3109/02713683.2015.1127390.
   PubMed Web of Science ®Google Scholar
• Arıkan Yorgun M, Toklu Y, Altınkaynak H, Tanrıverdi B, Ergin M, Biçer C, Novel A. Tool for the assessment oxidative stress in age-related macular degeneration: thiol/disulfide homeostasis revisited. Curr Eye Res. 2016;41:1584–89. doi:10.3109/02713683.2016.1141965.
   PubMed Web of Science ®Google Scholar
• Tetikoğlu M, Aktas S, Sağdik HM, Özcura F, Uçar F, Koçak H, Neşelioğlu S, Erel Ö. Thiol disulfide homeostasis in pseudoexfoliation syndrome. Curr Eye Res. 2017;42:876–79. doi:10.1080/02713683.2016.1256412.
   PubMed Web of Science ®Google Scholar
• Karakurt Y, Mertoglu C, Gok G, Ucak T, Tasli N, Icel E, Erel O. Thiol–disulfide homeostasis and serum ischemia modified albumin levels in patients with primary open–angle glaucoma. Curr Eye Res. 2019;44:896–900. doi:10.1080/02713683.2019.1594925.
   PubMed Web of Science ®Google Scholar
• Gulpamuk B, Tekin K, Sonmez K, Inanc M, Neselioglu S, Erel O, Yilmazbas P. The significance of thiol/disulfide homeostasis and ischemia-modified albumin levels to assess the oxidative stress in patients with different stages of diabetes mellitus. Scand J Clin Lab Invest. 2018;78:136–42. doi:10.1080/00365513.2017.1422540.
   PubMed Web of Science ®Google Scholar
• Ates I, Kaplan M, Inan B, Alisik M, Erel O, Yilmaz N, Guler S. How does thiol/disulfide homeostasis change in prediabetic patients? Diabetes Res Clin Pract. 2015;110:166–71. doi:10.1016/j.diabres.2015.09.011.
   PubMed Web of Science ®Google Scholar
• Aronson D. Hyperglycemia and the pathobiology of diabetic complications. In: cardiovascular diabetology: clinical, metabolic and inflammatory facets. Basel, Switzerland: KARGER. 2008; p. 1–16.
   Google Scholar
• Kowluru RA, Chan P-S. Oxidative stress and diabetic retinopathy. Exp Diabetes Res. 2007;2007:1–12.
   Google Scholar
• Reddy VS, Sethi S, Agrawal P, Gupta N, Garg R. Ischemia modified albumin (IMA) and albumin adjusted-IMA (AAIMA) as biomarkers for diabetic retinopathy. Nepal J Ophthalmol. 2016;7:117–23. doi:10.3126/nepjoph.v7i2.14960.
   Web of Science ®Google Scholar
• Kaefer M, Piva SJ, De Carvalho JAM, Da Silva DB, Becker AM, Coelho AC, Duarte MM, Moresco RN. Association between ischemia modified albumin, inflammation and hyperglycemia in type 2 diabetes mellitus. Clin Biochem. 2010;43:450–54. doi:10.1016/j.clinbiochem.2009.11.018.
   PubMed Web of Science ®Google Scholar
• Ukinc K, Eminagaoglu S, Ersoz HO, Erem C, Karahan C, Hacihasanoglu AB, Kocak M. A novel indicator of widespread endothelial damage and ischemia in diabetic patients: ischemia-modified albumin. Endocrine. 2009;36:425–32. doi:10.1007/s12020-009-9236-5.
   PubMed Web of Science ®Google Scholar
• Turk A, Nuhoglu I, Mentese A, Karahan SC, Erdol H, Erem C. The relationship between diabetic retinopathy and serum levels of ischemia-modified albumin and malondialdehyde. Retina. 2011;31(3):602–08. doi:10.1097/IAE.0b013e3181ed8cd1.
   PubMed Web of Science ®Google Scholar
• Ajlan RS, Silva PS, Sun JK. Vascular Endothelial Growth Factor and Diabetic Retinal Disease. Semin Ophthalmol. 2016;31:40–48. doi:10.3109/08820538.2015.1114833.
   PubMed Web of Science ®Google Scholar
• Wu L, Acón D, Wu A, Wu M. Vascular endothelial growth factor inhibition and proliferative diabetic retinopathy, a changing treatment paradigm? Taiwan J Ophthalmol. 2019;9:216. doi:10.4103/tjo.tjo_67_19.
   PubMedGoogle Scholar